转移性疾病患者行初次全髋与全膝关节置换术后的死亡率与并发症
基于美国国家手术质量改进计划2008至2018年数据库,分析择期初次全髋和全膝关节置换术中播散性癌症患者术后并发症。共纳入205007例全髋和352337例全膝关节置换患者,其中942例(0.2%)伴播散性癌症。调整协变量后,播散性癌症患者死亡、任何并发症、深静脉血栓、肺栓塞、心血管并发症、输血、再手术、再入院风险均更高,住院时间更长。
要点
- 播散性癌症患者择期初次全髋/全膝关节置换术后死亡风险约为无播散性癌症者的5.25倍。
- 播散性癌症患者任何并发症、深静脉血栓、肺栓塞、心血管并发症风险均升高。
- 播散性癌症患者再手术、再入院风险升高,住院时间更长(4.3天 vs 2.7天)。
核心结论
- 播散性癌症患者择期初次全髋和全膝关节置换术后并发症风险显著升高。
- 理解并发症的严重程度对于患者和外科医生考虑手术时的风险-获益分析至关重要。
研究设计与样本
- 回顾性分析美国国家手术质量改进计划数据库2008至2018年数据。
- 纳入择期初次全髋关节置换术患者205007例和全膝关节置换术患者352337例,其中942例(0.2%)伴播散性癌症。
- 采用卡方检验比较组间比例,采用单因素和多因素逻辑回归建模播散性癌症患者相对于无播散性癌症患者的比值比。
- 证据等级为II级。
主要发现
- 调整协变量后,播散性癌症患者死亡风险更高(OR 5.25,95% CI 2.47-11.17)。
- 播散性癌症患者任何并发症风险更高(OR 1.95,95% CI 1.63-2.33)。
- 播散性癌症患者深静脉血栓风险更高(OR 2.39,95% CI 1.32-4.35),肺栓塞风险更高(OR 3.07,95% CI 1.52-6.17)。
- 播散性癌症患者心血管并发症风险更高(OR 2.98,95% CI 1.47-6.04),输血风险更高(OR 2.21,95% CI 1.82-2.69)。
- 播散性癌症患者再手术风险更高(OR 1.89,95% CI 1.28-2.78),再入院风险更高(OR 2.51,95% CI 1.95-3.23),住院时间更长(4.3天 vs 2.7天)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although palliative therapies such as radiation are usually performed to improve quality of life in patients with metastatic disease, arthroplasty for joint pain may be indicated in some cases. Therefore, the purpose of this study is to evaluate the 30-day mortality risk, the risk of complications including infection and venous thromboembolic events, and the rate of 30-day reoperations and readmissions in patients with metastatic disease undergoing primary total hip and total knee arthroplasty (THA/TKA). METHODS: We reviewed the National Surgical Quality Improvement Program database from 2008 to 2018 to evaluate rates of postoperative complications after elective primary THA/TKA in patients with disseminated cancer. After exclusions, 205,007 patients undergoing primary THA and 352,337 undergoing primary TKA were retained for analysis: 942 (0.2%) with disseminated cancer. Chi-square was used to compare proportions between groups. Univariate and multivariate logistic regression was used to model the odds ratio of patients with disseminated cancer compared with those without disseminated cancer. RESULTS: After adjustment for covariates, patients with disseminated cancer had a higher risk of death (OR: 5.25, 95% CI: 2.47-11.17), any complication (OR: 1.95, 95% CI: 1.63-2.33), deep venous thrombosis (OR: 2.39, 95% CI: 1.32-4.35), pulmonary embolism (OR: 3.07, 95% CI: 1.52-6.17), cardiovascular complications (OR: 2.98, 95% CI: 1.47-6.04), transfusion (OR: 2.21, 95% CI: 1.82-2.69), reoperations (OR: 1.89, 95% CI: 1.28-2.78), readmissions (OR: 2.51, 95% CI: 1.95-3.23), and longer length of stay (4.3 vs 2.7 days). CONCLUSION: Patients with disseminated cancer have significantly elevated risk of complications after elective primary THA/TKA. Understanding the severity of complications is critical to the risk-benefit analysis that confronts patients and surgeons considering surgery. LEVEL OF EVIDENCE: II.
引用
- Sloan M, Lee GC. Mortality and Complications in Patients with Metastatic Disease after Primary Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2020. PMID: 32690429. doi:10.1016/j.arth.2020.06.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。